1. Home
  2. EDUC vs BLRX Comparison

EDUC vs BLRX Comparison

Compare EDUC & BLRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Educational Development Corporation

EDUC

Educational Development Corporation

HOLD

Current Price

$1.58

Market Cap

13.1M

ML Signal

HOLD

Logo BioLineRx Ltd.

BLRX

BioLineRx Ltd.

HOLD

Current Price

$3.18

Market Cap

12.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EDUC
BLRX
Founded
1965
2003
Country
United States
Israel
Employees
N/A
N/A
Industry
Consumer Specialties
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
13.1M
12.6M
IPO Year
1995
2010

Fundamental Metrics

Financial Performance
Metric
EDUC
BLRX
Price
$1.58
$3.18
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$19.00
AVG Volume (30 Days)
37.5K
14.7K
Earning Date
05-19-2026
05-26-2026
Dividend Yield
N/A
N/A
EPS Growth
142.86
N/A
EPS
0.27
N/A
Revenue
$22,913,600.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$5.70
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.01
$2.15
52 Week High
$1.84
$5.05

Technical Indicators

Market Signals
Indicator
EDUC
BLRX
Relative Strength Index (RSI) 64.10 54.03
Support Level $1.27 $3.05
Resistance Level $1.67 $3.51
Average True Range (ATR) 0.08 0.23
MACD 0.01 -0.02
Stochastic Oscillator 63.33 49.57

Price Performance

Historical Comparison
EDUC
BLRX

About EDUC Educational Development Corporation

Educational Development Corp distributes books and educational products and publications through its PaperPie and EDC Publishing divisions to individual consumers, book, toy and gift stores, libraries and home educators located throughout the United States. The company is the owner and exclusive publisher of Kane Miller children's books; Learning Wrap-Ups, maker of educational manipulatives; and SmartLab Toys, maker of STEAM-based toys and games. It also the exclusive United States Multi-Level Marketing (MLM) distributor of Usborne Publishing Limited (Usborne) children's books. It sell children's books, educational toys and games and other related products. It has two reportable segments: PaperPie and Publishing of which majority of revenue comes from Paperpie.

About BLRX BioLineRx Ltd.

BioLine Rx Ltd is a commercial-stage biopharmaceutical company focused on oncology. The company's current development and commercialization pipeline consists of two clinical-stage therapeutic candidates motixafortide (BL-8040), a novel peptide for the treatment of stem-cell mobilization and solid tumors, and AGI-134, an immuno-oncology agent in development for solid tumors. In addition, the company has a legacy therapeutic product called BL-5010 for the treatment of skin lesions. The company has generated revenues from milestone payments under previously existing out-licensing agreements.

Share on Social Networks: